+612 9045 4394
 
CHECKOUT
From Alchemy To Ipo : The Business Of Biotechnology - Cynthia Robbins-roth

From Alchemy To Ipo

The Business Of Biotechnology

Paperback

Published: 12th April 2001
Ships: 7 to 10 business days
7 to 10 business days
$47.50

"A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth."-Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers. "From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can."-George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, Amgen. Written by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market. This is the first book to accurately record the inner workings of an industry - biotechnology - that's on the verge of living up to its monumental promise to change the world as we know it.

"A fascinating glimpse inside the life-and-death business of biotechnology. A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth." -Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers "From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can." -George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, Amgen"

Prefacep. ix
Acknowledgmentsp. xiii
The Roots of Biotechnology
Biotech in the Beginningp. 3
Genentech: The Leader of the Packp. 13
The Amgen Storyp. 31
An Exception to Every Rule: Genzymep. 43
The Other Biotech: Monoclonal Antibodiesp. 48
Biotech's Building Blocks
Biotech Star Warsp. 59
The Human Genome Projectp. 67
Tools for Genome Studies: BioChips and Microarraysp. 73
Treating Disease at the Gene: Antisense Drugsp. 82
Gene Therapyp. 85
Following the Path of Communication: Signal Transductionp. 89
Brand-New Knees: Tissue Engineering and Cell Replacementp. 92
Building New Drugs: Combinatorial Chemistryp. 97
Agricultural Biotechnologyp. 105
The Business of Biotech: Product Development and Financing
The Drug Development Process: From Test Tubes to Patientsp. 111
Speed Bumps and Brick Walls: Clinical Trial Designp. 124
Biotech Bankersp. 131
Initial Public Offeringsp. 146
Creative Financingp. 155
Corporate Partners and the Urge to Mergep. 161
Biotech Stocks
The Biotech Stock Landscapep. 183
Picking the Right Stocksp. 198
Biotech Timelinep. 219
Biotechnology-Derived Products on the Marketp. 224
Biotech Web Sites and Resourcesp. 230
BioVenture Consultants' Biotech Stock Reportp. 235
Indexp. 243
Table of Contents provided by Syndetics. All Rights Reserved.

ISBN: 9780738204826
ISBN-10: 073820482X
Audience: General
Format: Paperback
Language: English
Number Of Pages: 272
Published: 12th April 2001
Country of Publication: US
Dimensions (cm): 22.9 x 15.3  x 1.6
Weight (kg): 0.39
Edition Number: 1